BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 953 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $607,000 | -12.5% | 7,571 | -6.1% | 0.60% | -21.0% |
Q2 2020 | $694,000 | +6.0% | 8,059 | 0.0% | 0.76% | -13.7% |
Q1 2020 | $655,000 | -27.1% | 8,059 | -22.9% | 0.88% | -8.7% |
Q4 2019 | $898,000 | -13.2% | 10,447 | -11.6% | 0.97% | -13.0% |
Q3 2019 | $1,035,000 | -8.5% | 11,823 | -14.3% | 1.11% | -12.7% |
Q2 2019 | $1,131,000 | +0.7% | 13,800 | 0.0% | 1.27% | -3.6% |
Q1 2019 | $1,123,000 | +20.1% | 13,800 | -2.8% | 1.32% | +13.3% |
Q4 2018 | $935,000 | -18.1% | 14,200 | -4.1% | 1.16% | +8.5% |
Q3 2018 | $1,141,000 | -1.6% | 14,800 | -5.7% | 1.07% | +17.9% |
Q2 2018 | $1,160,000 | +10.1% | 15,700 | -3.1% | 0.91% | +22.3% |
Q1 2018 | $1,054,000 | -1.9% | 16,200 | -2.4% | 0.74% | +15.3% |
Q4 2017 | $1,074,000 | -9.0% | 16,600 | -11.7% | 0.65% | -7.3% |
Q3 2017 | $1,180,000 | +0.4% | 18,800 | -3.1% | 0.70% | -27.8% |
Q2 2017 | $1,175,000 | +9.4% | 19,400 | -6.3% | 0.96% | -22.1% |
Q1 2017 | $1,074,000 | +9.0% | 20,700 | -6.8% | 1.24% | +10.0% |
Q4 2016 | $985,000 | +6.6% | 22,200 | +14.4% | 1.13% | +20.6% |
Q3 2016 | $924,000 | +5.2% | 19,400 | 0.0% | 0.93% | -1.0% |
Q2 2016 | $878,000 | – | 19,400 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |